MyPathway study: a novel precision oncology multiple basket trial
MyPathway study: a novel precision oncology multiple basket trial
Editor's Choice for June 2018
ASCO 2018 conference round up
Results from the phase I ICONIC trial
Aspirin combined with acid-reducing medicine offers moderate benefits in patients with Barrett’s oesophagus
Heated abdominal chemotherapy not beneficial in patients with advanced colorectal cancer
Comment: Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals
Comment: No benefit of heated abdominal chemotherapy in advanced colorectal cancer
Aspirin with acid-reducing medicine reduces chance of oesophageal cancer in high risk individuals
No benefit of heated abdominal chemotherapy in advanced colorectal cancer
What will we expect from novel therapies for oesophageal and gastric malignancies?
Linking Lynch Syndrome and microsatellite instability in tumours